CVS Health Corp.’s drug benefits unit is trying to entice health insurance plans to cover Wegovy, Novo Nordisk A/S’s pricey ...

It only arrived in the UK a little over 20 months ago, but since its release, Mounjaro has transformed the market for GLP-1 medicines, with more than half of the 1.5 million people taking weight-loss ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide ...

Patients on daily pill lost about 17% of body weight in trial Results nearly identical to injectable Wegovy New obesity pill ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...

As Eli Lilly and Novo Nordisk await approval of their oral GLP-1RAs, the healthcare editorial team discuss data and market opportunity.

New study finds weight-loss drugs Ozempic, Wegovy, and Mounjaro may make foods taste sweeter or saltier, helping users feel ...

Danish diabetes and obesity giant Novo Nordisk today announced positive results from the US-based INFORM survey of people taking Wegovy (semaglutide) for weight management at the European Association ...

Novo Nordisk A/S plans to seek US regulatory approval for a high-dose version of its blockbuster weight-loss shot Wegovy, ...